As of May 27
| +0.77 / +2.41%|
The 1 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +22.32% increase from the last price of 32.70.
The current consensus among 3 polled investment analysts is to Buy stock in Natus Medical Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.